Development of research laboratories (Q11404): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: summary (P836): SEEREON, s.r.o. has a long track record of R & D & I in the veterinary field. This project will allow the company to introduce new and increase existing capacities for the realisation of R & D & I activities. Within the framework of the project, R & D & I will be acquired which will meet the conditions of the pharmaceutical clean space. Within this space it will be possible to handle bacterial and viral agents, examine their properties and de...) |
(Created claim: summary (P836): The company SEVARON, s.r.o. has long been engaged in R & D & I in the veterinary field. This project will enable the company to introduce new and increase existing capacities for R & D & I activities. R & D & I capacities will be acquired as part of the project, which will meet the conditions of pharmaceutical clean space. Within these spaces it will be possible to manipulate bacterial and viral agents, examine their properties and develop thei...) |
||||||||||||||
| Property / summary | |||||||||||||||
The company SEVARON, s.r.o. has long been engaged in R & D & I in the veterinary field. This project will enable the company to introduce new and increase existing capacities for R & D & I activities. R & D & I capacities will be acquired as part of the project, which will meet the conditions of pharmaceutical clean space. Within these spaces it will be possible to manipulate bacterial and viral agents, examine their properties and develop their own new products taking into account the current needs of veterinary practice. a. (English) | |||||||||||||||
| Property / summary: The company SEVARON, s.r.o. has long been engaged in R & D & I in the veterinary field. This project will enable the company to introduce new and increase existing capacities for R & D & I activities. R & D & I capacities will be acquired as part of the project, which will meet the conditions of pharmaceutical clean space. Within these spaces it will be possible to manipulate bacterial and viral agents, examine their properties and develop their own new products taking into account the current needs of veterinary practice. a. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: The company SEVARON, s.r.o. has long been engaged in R & D & I in the veterinary field. This project will enable the company to introduce new and increase existing capacities for R & D & I activities. R & D & I capacities will be acquired as part of the project, which will meet the conditions of pharmaceutical clean space. Within these spaces it will be possible to manipulate bacterial and viral agents, examine their properties and develop their own new products taking into account the current needs of veterinary practice. a. (English) / qualifier | |||||||||||||||
point in time: 22 October 2020
| |||||||||||||||
Revision as of 15:34, 22 October 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of research laboratories |
Project in Czech Republic financed by DG Regio |
Statements
4,261,550.0 Czech koruna
0 references
8,523,100.0 Czech koruna
0 references
50 percent
0 references
31 August 2018
0 references
31 December 2019
0 references
SEVARON s.r.o.
0 references
49°13'35.62"N, 16°35'43.37"E
0 references
61200
0 references
Společnost SEVARON, s.r.o. se dlouhodobě zabývá VaVaI ve veterinární oblasti. Tento projekt společnosti umožní zavedení nových a zvýšení stávajících kapacit pro realizaci VaVaI aktivit. V rámci projektu budou pořízeny VaVaI kapacity, které budou splňovat podmínky farmaceutických čistých prostor. V rámci těchto prostor bude možno manipulovat s bakteriálními i virovými agens, zkoumat jejich vlastnosti a vyvíjet vlastní nové produkty s ohledem na aktuální potřeby veterinární praxe. a. (Czech)
0 references
The company SEVARON, s.r.o. has long been engaged in R & D & I in the veterinary field. This project will enable the company to introduce new and increase existing capacities for R & D & I activities. R & D & I capacities will be acquired as part of the project, which will meet the conditions of pharmaceutical clean space. Within these spaces it will be possible to manipulate bacterial and viral agents, examine their properties and develop their own new products taking into account the current needs of veterinary practice. a. (English)
22 October 2020
0 references
Identifiers
CZ.01.1.02/0.0/0.0/16_092/0008967
0 references